Ibrance vs Revlimid
Different cancer types: Ibrance for breast cancer, Revlimid for multiple myeloma. Both are oral cancer therapies with patient assistance programs.
Side-by-Side Comparison
| Ibrance | Revlimid | |
|---|---|---|
| Generic Name | Palbociclib | Lenalidomide |
| Manufacturer | Pfizer | Bristol-Myers Squibb |
| FDA Uses | HR+/HER2- metastatic breast cancer | Multiple myeloma, Myelodysplastic syndromes, Mantle cell lymphoma |
| Dosing | 125mg daily for 21 days, 7 days off | 25mg daily for 21 days, 7 days off |
| Monthly Cost | $14,000 | $16,000 |
| With Insurance | $0–$2,000 | $0–$2,000 |
| Common Side Effects | Fatigue, Nausea, Hair thinning | Fatigue, Diarrhea |
Explore your possible benefits
Your household may qualify for support from different programs. Answer a few questions to see which programs may fit your household.
Free · About 3 minutes · No credit card required
Frequently Asked Questions
Which is better, Ibrance or Revlimid?
Different cancer types: Ibrance for breast cancer, Revlimid for multiple myeloma. Both are oral cancer therapies with patient assistance programs. The best choice depends on your specific condition, insurance coverage, and how your body responds. Talk to your doctor about which is right for you.
Is Ibrance cheaper than Revlimid?
Ibrance costs $14,000/month while Revlimid costs $16,000/month without insurance. With insurance, copays may be similar depending on your plan's formulary.
Can I switch from Ibrance to Revlimid?
Switching between these medications should only be done under your doctor's supervision. They may need to adjust dosing and monitor for side effects during the transition.
Start with a free benefits check
We’ll email you a link to get started. Answer a few questions about your household to see your possible matches.
No spam. Unsubscribe anytime.
Need Help Affording Your Medication?
Check if you qualify for Medicaid, Medicare, or other programs that can cover your prescription costs.
Find my benefits →About 3 minutes · Free results · No credit card required